🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareSemaglutide and addictive behavior reduction — need advice Page 4

Semaglutide and addictive behavior reduction — need advice

Dr.RenalNash Fri, Sep 19, 2025 at 1:34 AM 30 replies 1,683 viewsPage 4 of 6
CarlaRPh_TPA
Senior Member
1,890
8,234
Jan 2024
Tampa, FL
Sep 21, 2025 at 2:04 AM#16

Clinical perspective, offered as context rather than as advice. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

5 5FDA_TrackerJim, ricardo_MIA, BrianDallas92 and 2 others
Reply Quote Save Share Report
Dr.EM_Chicago
Member
567
2,567
May 2024
Chicago, IL
Sep 21, 2025 at 5:12 AM#17

From the other side of the consultation, briefly. Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the correction. That is slower than asserting, and it is the only version that survives being wrong.

4 4matt_MKE, Dr.ReproEndo, lucas_SP_BR and 1 other
Reply Quote Save Share Report
wendy_avl
Member
245
1,123
Oct 2024
Asheville, NC
Sep 21, 2025 at 8:20 AM#18
Dr.EM_Chicago said:
Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the…

This matches mine closely enough to be worth saying so. The dose-response is real but shallow at the top. Across STEP 1 and STEP 4 the gap between 1.7mg and 2.4mg is a couple of percentage points of body weight on average, and the average is carrying a wide spread — plenty of people at 1.7mg sit above the 2.4mg mean. If a dose is working and tolerable, "working" is the relevant variable, not "maximal".

Last edited: Sep 21, 2025 at 2:20 PM
3 3TomTeleRx, DoseLogDan, SleepFixSam
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
nancy_portland
Member
345
1,567
Aug 2024
Portland, ME
Sep 21, 2025 at 11:28 AM#19
Dr.EM_Chicago said:
Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the…

Coming at Dr.EM_Chicago’s question from a different direction. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

Last edited: Sep 21, 2025 at 12:28 PM
2 2Dr.PeteFamMed, claudia_zurich
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Sep 21, 2025 at 2:36 PM#20

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source. Tagging this one for the weekly digest.

30 5PurityPaulOR, MaxMetOK, MounjBrad and 27 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register